Mulmit

Kura Oncology, Inc.Kura Oncology, Inc.

KURA Nasdaq

Annual financials

PeriodRevenueOperating incomeNet incomeEPS
2025-12-3167,482,000-303,631,000-278,666,000-3.18
2024-12-3153,883,000-193,195,000-173,983,000-2.02
2023-12-310-165,804,000-152,631,000-2.08

Insider filings (Forms 3/4/5)

DateOwnerTitleShares
2026-08-24WILSON TROY EDWARDPresident and CEO100,000
2026-08-21Powl Brian T.Chief Commercial Officer4,345
2026-08-19Bair Teresa BrophyChief Legal Officer31,487
2026-08-17WILSON TROY EDWARDPresident and CEO100,000
2026-06-18Leoni MollieChief Medical Officer84,929
2026-06-04Parks Diane L.35,000
2026-06-04VASCONCELLES MICHAEL35,000
2026-06-04Hasnain Faheem35,000
2026-06-04Collins Helen Louise35,000
2026-06-04SCHAFER CAROL35,000
2026-06-04Szela Mary T35,000
2026-06-04Malley Thomas35,000

8-K events

FiledItems
2026-09-09Other events
2026-09-08Officer or director change
2026-08-12Results of operations · Financial statements and exhibits
2026-07-29Officer or director change
2026-06-04Officer or director change · Submission of matters to a vote · Financial statements and exhibits
2026-05-12Results of operations · Financial statements and exhibits
2026-03-05Results of operations · Financial statements and exhibits
2026-01-29Amendments to charter or bylaws · Financial statements and exhibits
데이터를 불러오는 중입니다…Loading…

가격 차트Price chart

차트를 불러오는 중입니다…Loading chart…

Pharmaceutical Preparations — 같은 업종, 그리고 규모가 비슷한 기업Pharmaceutical Preparations — and other companies of a similar size

SEC가 같은 업종(Pharmaceutical Preparations)으로 분류한 기업이 먼저 오고, 그다음은 제출된 매출로 가까운 순입니다 — 가장 최근 연간 값이며, 연간 값이 없으면 최근 네 분기 합입니다. Companies the SEC assigns to the same industry (Pharmaceutical Preparations) come first, then the nearest by revenue as filed — the latest annual figure, or the last four quarters where no annual one is filed. 순서일 뿐 값이 싸거나 비싸다는 뜻이 아닙니다.Order only — it does not say a company is cheap or expensive.